Evidence mapPaperPMID 34207164Full record

ArticleInternational journal of environmental research and public health2021

Assessment of Glycosylated Hemoglobin Outcomes Following an Enhanced Medication Therapy Management Service via Telehealth.

Jennifer M Bingham, Jennifer Stanislaw, Terri Warholak, Nicole Scovis, David R Axon, Jacques Turgeon, Srujitha Marupuru

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Jennifer M BinghamTabula Rasa HealthCare, Tucson, AZ 85701, USA.ORCID 0000-0003-4892-7879
Jennifer StanislawCollege of Pharmacy, University of Arizona, Tucson, AZ 85721, USA.
Terri WarholakCollege of Pharmacy, University of Arizona, Tucson, AZ 85721, USA.
Nicole ScovisTabula Rasa HealthCare, Tucson, AZ 85701, USA.ORCID 0000-0001-5612-8087
David R AxonCollege of Pharmacy, University of Arizona, Tucson, AZ 85721, USA.ORCID 0000-0002-9903-5996
Jacques TurgeonTabula Rasa HealthCare, Precision Pharmacotherapy Research and Development Institute, Orlando, FL 32827, USA.ORCID 0000-0002-7978-9280
Srujitha MarupuruCollege of Pharmacy, University of Arizona, Tucson, AZ 85721, USA.ORCID 0000-0003-3786-2846
University of Arizona · USResearch & Development Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: Regular contact with a medication therapy management (MTM) pharmacist is shown to improve patients' understanding of their condition; however, continued demonstration of the value of a pharmacist delivered comprehensive medication review (CMR) using enhanced MTM services via telehealth is needed. The study aimed to describe a pilot program designed to improve type 2 diabetes mellitus (T2DM) management through enhanced condition specific MTM services. (2) Methods: This retrospective study included patients with T2DM aged 40-75 years who received a pharmacist-delivered CMR between January and December 2018. An evaluation of glycosylated hemoglobin (HbA1c) values 3 months pre- and post-CMR was performed. Wilcoxon signed-rank and chi-square tests were used. (3) Results: Of 444 eligible patients, a majority were female (58%) with a median age of 70 years. Median HbA1c values post-CMR were lower than pre-CMR (median 7.1% range 4.5-13.6; median 7.4% range 4.5-13.9, respectively;

Indexed as

Diabetes Mellitus, Type 2TelemedicineAgedFemaleGlycated HemoglobinHumansMaleMedication Therapy ManagementPharmacistsRetrospective StudiesGlycated Hemoglobincomprehensive medication reviewglycosylated hemoglobinmedication therapy managementpharmacistT2DMtelehealthtype 2 diabetes

Identifiers

PMID34207164
PMCPMC8296452
OpenAlexW3177388433

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.